Cellular Biomedicine Group to Report Fourth Quarter and Full Year 2019 Results on February 28, 2020


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


NEW YORK and SHANGHAI, Feb. 26, 2020 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2019 after the market closes on Friday, February 28, 2020.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

The Company will host a conference call and webcast with the investment community on Friday, February 28 th at 4:30 p.m. Eastern Time, featuring remarks by Tony Liu, Executive Director, CEO and CFO of CBMG.

What:

Cellular Biomedicine Fourth Quarter and Full Year 2019 Results Conference Call



Date:

Friday, February 28, 2020



Time:

4:30 p.m. Eastern Time



Live Call:

Toll-Free: 1-877-423-9813

International: 1-201-689-8573



Webcast:

http://public.viavid.com/index.php?id=138289



Replay:

Toll-Free: 1-844-512-2921

International: 1-412-317-6671

Conference ID: 13699688

(Available approximately two hours after the completion of the live call until 11:59 p.m. ET on March 13, 2020)

About Cellular Biomedicine Group, Inc.
Cellular Biomedicine Group, Inc. is a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases. For more information, please visit https://www.cellbiomedgroup.com/.

For more information, please contact:

Company Contact:
Derrick C. Li
Head of Strategy and Investor Relations, CBMG
Phone: 917-717-0994
Email: derrick.li@cellbiomedgroup.com

Investor Contact:
Valter Pinto / Allison Soss
KCSA Strategic Communications
Phone: 212-896-1254 / 212-896-1267
Email: cellbiomed@kcsa.com   

View original content to download multimedia:http://www.prnewswire.com/news-releases/cellular-biomedicine-group-to-report-fourth-quarter-and-full-year-2019-results-on-february-28-2020-301011725.html

SOURCE Cellular Biomedicine Group, Inc.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Press ReleasesConference Call Announcements